Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus.

Lisa ZhuManpreet SinghSonia LeleLori SahakianJennifer GrossmanBevra HahnMaureen McMahon

Published in: Lupus science & medicine (2022)

Both QRISK3 and PREDICTS demonstrated better performance in predicting risk of cardiovascular disease in this cohort of patients with SLE compared with FRS, modified FRS and ASCVD.

Keyphrases

cardiovascular events
cardiovascular disease
coronary artery disease
systemic lupus erythematosus
type diabetes
disease activity
rheumatoid arthritis